Search

Home > GRACEcast Lung Cancer Video > CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients
Podcast: GRACEcast Lung Cancer Video
Episode:

CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients
Category: Science & Medicine
Duration: 00:02:27
Publish Date: 2014-05-11 14:00:00
Description:

Dr. Heather Wakelee of Stanford University Medical Center talks about a drug still in development for EGFR lung cancer patients, CO-1686. February 2014.
Total Play: 0